Election 2014
SENSEX NIFTY
Brawn Biotech Chairman's Speech > Engineering - Heavy > Chairman's Speech from Brawn Biotech - BSE: 530207, NSE: N.A
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > CHAIRMANS SPEECH - Brawn Biotech
Brawn Biotech
BSE: 530207|ISIN: INE899B01015|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
, 16:01
5.16
0
VOLUME 100
Brawn Biotech is not listed on NSE
Chairman's Speech (Brawn Biotech) Year : Mar '09
Dear Shareholders, 
 
 I extend hearty welcome to you on the eve of the Annual General Meeting 
 of the Company.
 
 At the very outset, I would like to share with all of you my deep sense
 of satisfaction over the sterling .  results achieved by your Company.
 I am extremely happy to report to you that despite, all adverse and
 challenging circumstances, your Company has fared very well during this
 year. Your company is trying to reduce the debt, increase the
 profitability and significantly improve the networth.
 
 The year 2008-09 has been odd year globally for number of significant
 reasons. Meltdown of major economies, world wide recession, liquidity
 crunch, de-growth in GDPs, unprecedented jobs cuts, near bankruptcy
 situation for many corporate giants of the developed countries and
 increased threat of terrorism than ever before impacted the lives of
 human beings.
 
 India was not immune to these events. However, Indian financial and
 banking sector was stable and timely economic stimulants implemented by
 the Government brought stability. Further boost was received by peoples
 mandate to a stable Government at the centre. Opening up of financial
 and insurance sectors to foreign investors and thrust given to the
 growth has helped the country in maintaining sustained growth and
 thereby boosting up investors confidence in the Indian economy.
 
 While all these events happening around the world, no exception to our
 country, your Company has recorded an unprecedented growth in income
 from operations and recorded increase in profits before tax to Rs.
 41.41 Lacs. Revenues for the year at Rs. 409.94 lacs were higher by
 442.41% compared to the previous year.
 
 This was achieved through an increased focus on securing profitable
 jobs and implementing a sustained efficiency program across the
 enterprise , which includes working towards improving cash collection,
 controlling expenditure and optimizing its resources wherever possible.
 These initiatives are showing visible success in all major financial
 indicators of your Companys results for the year.
 
 In view of the increasing profits , your company need to vipe off its
 losses accumulated over the years & thus is unable tp distribute any
 dividends. Still, we hope that if the progress goes on like this, we
 will be distributing dividends soon.
 
 I am please to inform that the Bombay Stock Exchange has revoked the
 suspension of trading on - the equity shares of the Company with effect
 from 29th May 2009. Thus the trading of the shares of the Company has
 started on Bombay Stock Exchange. Soon the Delhi Stock Exchange is also
 starting its Online trading Platform facilitating trading on the equity
 share of the Company at the PSEs trading terminals across the country.
 
 Finally, I wish to record my sincere thanks to Brawn Group for their
 unstinted support and contribution in turnaround of your Company. I
 also wish to place on record thanks to my colleagues on the Board,
 shareholders, suppliers, customers, bankers and employees at all levels
 for their continued support.
 
 B. R. Gupta 
 CHAIRMAN
Source : Dion Global Solutions Limited
Quick Links for brawnbiotech
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.